Protecting Axons
Protecting Patients

Creating breakthrough therapeutics for neurological diseases

cADPR and NF-L are SARM1-Dependent Biomarkers of Axonal Structure and Function that Enable Therapeutic Discovery and Clinical Translation

March 11, 2019

publication

+

Disarm Therapeutics Presents New Data Validating Role of SARM1 in Axonal Degeneration

November 3, 2018

press release

+

A New Approach to Treating Multiple Sclerosis

News

+